Knowledge and Attitudes of Parents of School-Aged Children Regarding Vaccinations, and an Analysis of Measles and Pertussis Vaccination Coverage Using the Example of the City of Radomsko in Central Poland
Abstract
1. Introduction
1.1. Immunization Programs in Other Countries
1.2. Vaccination Surveillance in Poland
1.3. Characteristics of Pertussis and Measles
- Catarrhal stage: Resembles a common cold (rhinitis, low-grade fever, and mild cough). This phase lasts approximately 1–2 weeks and is the most infectious.
- Paroxysmal stage: Features episodes of suffocating cough ending with “wheezing” breathing.
- Convalescent stage.
2. Materials and Methods
2.1. Study Design
2.2. Study Setting
2.3. Cross-Sectional Survey on Parental Knowledge and Opinions
2.4. Research Instrument
- Questions on the socio-demographic characteristics of respondents
- Questions assessing knowledge about vaccinations.
- Parental practices regarding child vaccinations.
- Assessment of access to vaccination-related information.
- The validated ‘Vaccination Attitudes Examination (VAX) Scale’, evaluating respondents’ attitudes towards protective vaccinations. The translation into Polish was performed by Borchet, Iwanowska (Institute of Psychology, Faculty of Social Sciences, University of Gdańsk), Bałandynowicz-Panfil (Department of Sustainable Market Processes, Faculty of Economics, University of Gdańsk), and Łosiewicz (Institute of Media, Journalism and Social Communication, Faculty of Social Sciences, University of Gdańsk) [41,42].
2.5. Epidemiological Data from the Vaccination Surveillance System
- •
- Primary vaccinations;
- •
- Booster doses;
- •
- Unvaccinated individuals (for primary, catch-up, and booster immunizations).
2.6. Statistical Analysis
Questionnaire Survey
- •
- Declared familiarity with the concept of protective vaccination and the mandatory vaccination schedule;
- •
- Was able to name at least several (five or more) diseases covered by mandatory vaccinations and several recommended vaccinations;
- •
- Was aware of potential consequences of not vaccinating children (e.g., increased risk of contracting diseases, resurgence of already eliminated diseases, threat to immunocompromised individuals);
- •
- Knew possible, actual adverse effects of vaccines;
- •
- Expressed belief in the benefits resulting from protective vaccinations (e.g., reduction in disease incidence, protection of society);
- •
- Demonstrated familiarity with concepts such as herd immunity or eradication of infectious diseases (e.g., by indicating smallpox as an example of a disease fully eliminated thanks to vaccinations).
- Mistrust of Vaccine Benefit—Measures the belief that vaccines are not effective or do not provide real benefits (e.g., “I am not convinced that vaccinations actually prevent diseases.”).
- Worries about Unforeseen Future Effects—Concerns fear of long-term, unknown effects of vaccinations (e.g., “I worry that vaccines may cause side effects that will only appear years later.”).
- Concerns about Commercial Profiteering—Refers to suspicions that vaccinations are promoted mainly for the profit of pharmaceutical companies and institutions (e.g., “Pharmaceutical companies promote vaccines only to make money.”).
- Preference for Natural Immunity—Expresses the belief that contracting the disease is better than receiving the vaccine (e.g., “I prefer to acquire immunity naturally rather than get vaccinated.”).
- Low vs. high mistrust in vaccine effectiveness (VAX_Mistrust);
- Low vs. high concerns about side effects (VAX_Worries);
- Low vs. high distrust of industry and authorities (VAX_Profiteering);
- Low vs. high preference for natural immunity (VAX_NaturalImmunity).
- •
- Low attitude level corresponded to a sum score of 3 to 10 points;
- •
- High attitude level corresponded to 11–18 points.
2.7. Reliability Analysis
2.8. Epidemiological Data
3. Results
3.1. Characteristics of the Study Group
3.2. Knowledge About Protective Vaccinations
3.3. Attitudes Towards Vaccinations
Variable | Type of Vaccine/Behavior | OR | 95% CI | Statistical Significance |
---|---|---|---|---|
Education | ||||
Measles | 1.10 | 0.68–1.76 | 0.73 | |
Pertussis | 2.03 | 1.27–3.27 | 0.0023 | |
Measles + Pertussis | 1.83 | 1.14–2.97 | 0.0097 | |
All mandatory vaccinations | 2.37 | 0.87–6.08 | 0.067 | |
Knowledge Index | ||||
Adherence to vaccination schedule | 3.92 | 2.13–7.20 | 4.49 × 10−6 | |
Acceptance of additional (recommended) vaccinations | 4.24 | 2.47–7.53 | 1.14 × 10−8 | |
Measles | 2.84 | 1.73–4.68 | 1.40 × 10−5 | |
Pertussis | 9.64 | 5.17–19.19 | 2.50 × 10−17 | |
Measles + Pertussis | 9.08 | 4.71–18.96 | 1.44 × 10−15 | |
All mandatory vaccinations | 1.44 | 0.45–3.96 | 0.43 |
3.4. Epidemiological Statistical Data—Analysis of Vaccine Refusals in Radomsko County and Radomsko City, 2014–2019
4. Discussion
- •
- Failure to perceive consequences of non-vaccination (11.5% of respondents);
- •
- Denial of vaccine benefits (5%);
- •
- Strong belief in ‘natural immunity’ (observed in 83.33% of non-vaccinators).
- •
- Healthcare knowledge deficits, particularly regarding the Immunization Program (only 73.4% claimed familiarity) and vaccine-preventable diseases.
- •
- •
- Lower education levels—Significantly associated with limited comprehension of key concepts (herd immunity, public health).
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Minor, P.D. Live attenuated vaccines: Historical successes and current challenges. Virology 2015, 479–480, 379–392. [Google Scholar] [CrossRef]
- Nandi, A.; Shet, A. Why vaccines matter: Understanding the broader health, economic, and child development benefits of routine vaccination. Hum. Vaccin. Immunother. 2020, 16, 1900–1904. [Google Scholar] [CrossRef]
- Gostin, L.O.; Sridhar, D. Global health and the law. N. Engl. J. Med. 2014, 370, 1732–1740. [Google Scholar] [CrossRef]
- D’Ancona, F.; VENICE II Group. VENICE II: Go on combining our efforts towards a European common vaccination policy. Euro Surveill. 2009, 14, 19161. [Google Scholar]
- Hohan, R.; Surleac, M.; Miron, V.D.; Tudor, A.; Tudor, A.-M.; Săndulescu, O.; Vlaicu, O.; Aramă, V.; Pițigoi, D.; Hristea, A.; et al. Ongoing measles outbreak in Romania: Clinical investigation and molecular epidemiology performed on whole genome sequences. PLoS ONE 2025, 20, e0317045. [Google Scholar] [CrossRef]
- Schmid-Küpke, N.; Kranz, L.; Rehfuess, E.; Wichmann, O.; Neufeind, J. Evaluation der Umsetzung der Masern- und COVID-19 Impfpflichten in Gesundheitsämtern und Gesundheitseinrichtungen: 2 Fallstudien. Bundesgesundheitsbl 2025, 68, 432–443. [Google Scholar] [CrossRef]
- Vaz, O.M.; Ellingson, M.K.; Weiss, P.; Jenness, S.M.; Bardají, A.; Bednarczyk, R.A.; Omer, S.B. Mandatory vaccination in Europe. Pediatrics 2020, 145, e20190620. [Google Scholar] [CrossRef] [PubMed]
- Attwell, K.; Drislane, S. Australia’s ‘No Jab No Play’ policies: History, design and rationales. Aust. N. Z. J. Public Health 2022, 46, 640–646. [Google Scholar] [CrossRef]
- Chief Sanitary Inspectorate. Komunikat Głównego Inspektora Sanitarnego w sprawie Programu Szczepień Ochronnych na rok 2025 [Internet]; Government of Poland: Warsaw, Poland, 2024. Available online: https://www.gov.pl/web/gis (accessed on 31 October 2024).
- World Health Organization. Measles vaccines: WHO position paper, April 2017—Recommendations. Vaccine 2019, 37, 219–222. [Google Scholar] [CrossRef] [PubMed]
- World Health Organization. Pertussis vaccines: WHO position paper, August 2015—Recommendations. Vaccine 2016, 34, 1423–1425. [Google Scholar] [CrossRef] [PubMed]
- National Institute of Public Health—National Institute of Hygiene, Chief Sanitary Inspectorate. Infectious Diseases and Poisonings in Poland in 2014; NIPH–NIH: Warsaw, Poland, 2015. [Google Scholar]
- National Institute of Public Health—National Institute of Hygiene, Chief Sanitary Inspectorate. Infectious Diseases and Poisonings in Poland in 2015; NIPH–NIH: Warsaw, Poland, 2016. [Google Scholar]
- National Institute of Public Health—National Institute of Hygiene, Chief Sanitary Inspectorate. Infectious Diseases and Poisonings in Poland in 2016; NIPH–NIH: Warsaw, Poland, 2017. [Google Scholar]
- National Institute of Public Health—National Institute of Hygiene, Chief Sanitary Inspectorate. Infectious Diseases and Poisonings in Poland in 2017; NIPH–NIH: Warsaw, Poland, 2018. [Google Scholar]
- National Institute of Public Health—National Institute of Hygiene, Chief Sanitary Inspectorate. Infectious Diseases and Poisonings in Poland in 2018; NIPH–NIH: Warsaw, Poland, 2019. [Google Scholar]
- National Institute of Public Health—National Institute of Hygiene, Chief Sanitary Inspectorate. Infectious Diseases and Poisonings in Poland in 2019; NIPH–NIH: Warsaw, Poland, 2020. [Google Scholar]
- National Institute of Public Health—National Institute of Hygiene, Chief Sanitary Inspectorate. Infectious Diseases and Poisonings in Poland in 2020; NIPH–NIH: Warsaw, Poland, 2021. [Google Scholar]
- National Institute of Public Health—National Institute of Hygiene, Chief Sanitary Inspectorate. Infectious Diseases and Poisonings in Poland in 2021; NIPH–NIH: Warsaw, Poland, 2022. [Google Scholar]
- National Institute of Public Health—National Institute of Hygiene, Chief Sanitary Inspectorate. Infectious Diseases and Poisonings in Poland in 2022; NIPH–NIH: Warsaw, Poland, 2023. [Google Scholar]
- National Institute of Public Health—National Institute of Hygiene, Chief Sanitary Inspectorate. Infectious Diseases and Poisonings in Poland in 2023; NIPH–NIH: Warsaw, Poland, 2024. [Google Scholar]
- Lauria, A.M.; Zabbo, C.P. Pertussis. In StatPearls [Internet]; StatPearls Publishing: Treasure Island, FL, USA, 2022. Available online: https://www.ncbi.nlm.nih.gov/books/NBK519008/ (accessed on 12 June 2025).
- Rosłonkiewicz-Wiechowska, K. Pertussis—An old disease and new prevention methods. Forum Med. Rodz. 2017, 11, 107–113. [Google Scholar]
- European Centre for Disease Prevention and Control. Pertussis. In Annual Epidemiological Report for 2022; ECDC: Stockholm, Sweden, 2024. [Google Scholar]
- European Centre for Disease Prevention and Control. Pertussis. In Annual Epidemiological Report for 2021; ECDC: Stockholm, Sweden, 2024. [Google Scholar]
- European Centre for Disease Prevention and Control. Pertussis. In Annual Epidemiological Report for 2018; ECDC: Stockholm, Sweden, 2020. [Google Scholar]
- European Centre for Disease Prevention and Control. Pertussis. In Annual Epidemiological Report for 2017; ECDC: Stockholm, Sweden, 2019. [Google Scholar]
- European Centre for Disease Prevention and Control. Pertussis. In Annual Epidemiological Report for 2016; ECDC: Stockholm, Sweden, 2018. [Google Scholar]
- European Centre for Disease Prevention and Control. Pertussis. In Annual Epidemiological Report for 2015; ECDC: Stockholm, Sweden, 2017. [Google Scholar]
- European Centre for Disease Prevention and Control. Pertussis. In Annual Epidemiological Report for 2014; ECDC: Stockholm, Sweden, 2016. [Google Scholar]
- National Institute of Public Health—National Institute of Hygiene, Chief Sanitary Inspectorate. Infectious Diseases and Poisonings in Poland in 2024; NIPH–NIH: Warsaw, Poland, 2025. [Google Scholar]
- World Health Organization Regional Office for Europe. European Health Report 2024, Keeping Health High on the Agenda; WHO: Copenhagen, Denmark, 2024. [Google Scholar]
- Kondamudi, N.P.; Waymack, J.R. Measles. In StatPearls [Internet]; StatPearls Publishing: Treasure Island, FL, USA, 2025. Available online: https://www.ncbi.nlm.nih.gov/books/NBK448068/ (accessed on 12 June 2025).
- Mucha, D.; Łubkowska, B.; Jeżewska-Frąckowiak, J.; Skowron, P.M. Evaluation of WHO measles eradication programme for the European region of 53 countries with emphasis on Poland in the years 2003–2014. Trop. Med. Infect. Dis. 2025, 10, 43. [Google Scholar] [CrossRef]
- Marchewka, A.K.; Woźniak, A.; Majewska, A.; Młynarczyk, G. Progress and problems in implementation of the program of elimination and eradication of measles, rubella and congenital rubella in Europe. Forum Zakażeń 2017, 8, 219–225. [Google Scholar] [CrossRef]
- European Centre for Disease Prevention and Control. Measles. In Annual Epidemiological Report for 2018; ECDC: Stockholm, Sweden, 2020. [Google Scholar]
- European Centre for Disease Prevention and Control. Measles. In Annual Epidemiological Report for 2019; ECDC: Stockholm, Sweden, 2021. [Google Scholar]
- European Centre for Disease Prevention and Control. Measles. In Annual Epidemiological Report for 2022; ECDC: Stockholm, Sweden, 2023. [Google Scholar]
- Statistics Poland. Local Data Bank (BDL) [Internet]. Available online: https://bdl.stat.gov.pl/bdl/dane/teryt/tablica (accessed on 12 June 2025).
- Radomsko City Council. Radomsko w liczbach [Radomsko in Numbers] [Internet]. Available online: https://www.radomsko.pl/miasto-otwarte2/o-radomsku/radomsko-w-liczbach (accessed on 12 June 2025).
- VAX-Scale. The Vaccination Attitudes Examination (VAX) Scale [Internet]. Available online: https://www.vax-scale.com/ (accessed on 30 May 2025).
- Borchet, J.; Iwanowska, A.; Bałandynowicz-Panfil, K.; Łosiewicz, A. Vaccination Attitudes Scale (VAS).
- Polish Parliament. Act of 14 March 1985 on the State Sanitary Inspection (Journal of Laws 1985 No. 12, item 49, as amended) [Internet]; Sejm of the Republic of Poland: Warsaw, Poland, 1985. Available online: https://isap.sejm.gov.pl (accessed on 12 June 2025).
- Cronbach, L.J. Coefficient alpha and the internal structure of tests. Psychometrika 1951, 16, 297–334. [Google Scholar] [CrossRef]
- Bianco, A.; Mascaro, V.; Zucco, R.; Pavia, M. Parent perspectives on childhood vaccination: How to deal with vaccine hesitancy and refusal? Vaccine 2019, 37, 984–990. [Google Scholar] [CrossRef]
- Iova, C.F.; Badau, D.; Daina, M.D.; Șuteu, C.L.; Daina, L.G. Knowledge, attitudes, intentions and vaccine hesitancy among postpartum mothers in a region from the Northwest of Romania. Vaccines 2023, 11, 1736. [Google Scholar] [CrossRef] [PubMed]
- Pieszka, M.; Waksmańska, W.; Woś, H. Parents’ knowledge of immunization in children under two years of age. Med. Og. Nauk. Zdr. 2016, 22, 221–226. [Google Scholar] [CrossRef]
- Johns, N.E.; Cata-Preta, B.O.; Kirkby, K.; Arroyave, L.; Bergen, N.; Danovaro-Holliday, M.C.; Santos, T.M.; Yusuf, N.; Barros, A.J.D.; Hosseinpoor, A.R. Inequalities in immunization against maternal and neonatal tetanus: A cross-sectional analysis of protection at birth coverage using household health survey data from 76 countries. Vaccines 2023, 11, 752. [Google Scholar] [CrossRef] [PubMed]
- Martin, L.R.; Petrie, K.J. Understanding the dimensions of anti-vaccination attitudes: The Vaccination Attitudes Examination (VAX) Scale. Ann. Behav. Med. 2017, 51, 652–660. [Google Scholar] [CrossRef]
- Sturm, L.; Kasting, M.L.; Head, K.J.; Hartsock, J.A.; Zimet, G.D. Influenza vaccination in the time of COVID-19, A national U.S. survey of adults. Vaccine 2021, 39, 1921–1928. [Google Scholar] [CrossRef]
- Łoś-Rycharska, E.; Popielarz, M.; Wolska, J.; Sobieska-Poszwa, A.; Dziembowska, I.; Krogulska, A. The antivaccination movement and the perspectives of Polish parents. Pediatr. Pol. 2022, 97, 183–192. [Google Scholar] [CrossRef]
- Wojtyczka, O.; Wójcik, M.; Bieżyńska, H.; Bielec, F.; Pastuszak-Lewandoska, D. Attitudes towards immunization and the state of knowledge about vaccines among Polish students. J. Health Inequal. 2022, 8, 108–118. [Google Scholar] [CrossRef]
- Rodriguez, V.J.; Kozlova, S.; LaBarrie, D.L.; Liu, Q. Parental anxiety and pediatric vaccine refusal in a US national sample of parents. Vaccine 2023, 41, 7072–7075. [Google Scholar] [CrossRef]
- Ulaszewska-Kieruzal, K.; Urbański, M.; Kasiak, P.; Gąsior, J.; Parol, D.; Wierzbiński, P.; Barylski, M.; Poliwczak, A.R.; Mamcarz, A.; Śliż, D. Social perceptions of COVID-19 and vaccinations: Survey findings. Med. Res. J. 2024, 9, 379–386. [Google Scholar] [CrossRef]
- UNICEF. The State of the World’s Children 2023, For Every Child, Vaccination [Internet]; UNICEF: New York, NY, USA, 2023; Available online: https://www.unicef.org/press-releases/sowc_2023_immunization (accessed on 11 July 2025).
- Wilson, S.L.; Wiysonge, C. social media and vaccine hesitancy. BMJ Glob. Health 2020, 5, e004206. [Google Scholar] [CrossRef] [PubMed]
Vaccine | Mandatory | Recommended |
---|---|---|
Tuberculosis (BCG) | ✓ | |
Hepatitis B | ✓ | |
Diphtheria, Tetanus, Pertussis (DTP) | ✓ | |
Haemophilus influenzae type b (Hib) | ✓ | |
Poliomyelitis | ✓ | |
Rotavirus | ✓ | |
Pneumococcal | ✓ | |
Measles, Mumps, Rubella (MMR) | ✓ | |
Human Papillomavirus (HPV) | ✓ * | |
COVID-19 | ✓ ** | |
Meningococcal | ✓ | |
Varicella (Chickenpox) | ✓ | |
Tick-borne Encephalitis (TBE) | ✓ | |
Hepatitis A | ✓ | |
Influenza | ✓ *** |
Subscale | Cronbach’s α | 95% Confidence Interval for α | Lambda 6 (G6) |
---|---|---|---|
Mistrust | 0.96 | [0.954; 0.966] | 0.94 |
Worries | 0.89 | [0.873; 0.907] | 0.84 |
Natural Immunity | 0.91 | [0.893; 0.927] | 0.88 |
Profiteering | 0.91 | [0.894; 0.926] | 0.87 |
Overall VAX | 0.94 | [0.932; 0.948] | 0.96 |
Variable | N (%) |
---|---|
Sex | |
Male | 19 (4.14) |
Female | 436 (94.99) |
Prefer not to say | 4 (0.87) |
Age group (years) | |
24–33 | 85 (18.50) |
34–43 | 270 (58.80) |
44–53 | 101 (22.0) |
54–63 | 3 (0.70) |
Education level | |
Primary | 12 (2.61) |
Secondary | 90 (19.61) |
Bachelor’s | 43 (9.37) |
Master’s | 308 (67.10) |
PhD or higher | 6 (1.31) |
Socioeconomic status | |
Low income | 49 (10.68) |
Middle income | 353 (76.91) |
High income | 57 (12.42) |
Employment status | |
Unemployed | 42 (9.15) |
Employed | 405 (88.24) |
Student | 12 (2.61) |
Number of children | |
1 | 403 (87.80) |
2 | 56 (12.20) |
N (%) | |
---|---|
Are you familiar with what a protective vaccination is? | |
Yes | 445 (96.95) |
No | 1 (0.22) |
Not sure | 13 (2.83) |
Please indicate which diseases are covered by mandatory vaccinations in Poland (multiple selections allowed) | |
Measles * | 424 (92.37) |
Pertussis * | 391 (85.19) |
Poliomyelitis * | 335 (72.98) |
Varicella ** | 171 (37.25) |
Diphtheria * | 357 (77.78) |
Tetanus * | 366 (79.74) |
Hepatitis B * | 291 (63.40) |
Hepatitis A ** | 61 (13.29) |
Pneumococci * | 5 (1.09) |
Rotaviruses * | 4 (0.87) |
Don’t know | 6 (1.31) |
Please indicate which diseases have vaccines recommended (but not mandatory) in Poland (multiple selections allowed) | |
Influenza ** | 366 (79.74) |
Human papillomavirus ** | 356 (77.56) |
Rotaviruses * | 359 (78.21) |
Pneumococci * | 367 (79.96) |
Meningococci ** | 329 (71.68) |
Tick-borne encephalitis ** | 242 (52.72) |
Varicella ** | 276 (60.13) |
Hepatitis A ** | 172 (37.47) |
Don’t know | 23 (5.01) |
Please select the most important benefit of vaccinations (choose one primary answer) | |
Protection against infectious diseases | 165 (35.90) |
Protection of individuals who cannot be vaccinated (herd immunity) | 1 (0.22) |
Reduction of epidemic risk | 43 (9.37) |
Reduction of disease severity if infected (less hospitalization/death) | 225 (49.02) |
In my view, vaccinations provide no meaningful benefits | 24 (5.23) |
Please indicate potential consequences of not vaccinating a child (multiple selections allowed) | |
Higher risk of disease complications | 349 (76.03) |
Increased likelihood of infection | 318 (69.28) |
Risk to other children | 215 (46.84) |
Possible exclusion from school/preschool | 63 (13.73) |
In my view, there are no negative consequences of not vaccinating children | 53 (11.55) |
Please indicate what the most common side effects of vaccinations are (multiple selections allowed) | |
Pain at the injection site | 366 (79.74) |
Fever | 400 (87.15) |
Rash | 126 (27.45) |
Fatigue | 146 (31.81) |
Excessive crying | 57 (12.42) |
Have you heard of the MMR vaccine (measles, mumps, rubella)? | |
Yes | 403 (87.80) |
No | 56 (12.20) |
Please specify which complications may occur following measles infection (multiple selections allowed) | |
Cutaneous manifestation | 114 (24.84) |
Encephalitis | 208 (45.32) |
Pneumonia | 127 (27.67) |
Ocular complications | 86 (18.74) |
Don’t know | 168 (36.60) |
Please enumerate the potential complications associated with pertussis infection (multiple selections allowed) | |
Paroxysmal coughing spells | 231 (50.33) |
Respiratory failure | 260 (56.64) |
Bacterial pneumonia | 260 (56.64) |
Pertussis encephalopathy | 78 (16.99) |
Don’t know | 87 (18.95) |
Answers to the Questionnaire Questions | Education Level | Statistical Significance | |
---|---|---|---|
Primary/Secondary n = 102 N (%) | Higher Education n = 357 N (%) | ||
Do you know what a preventive (protective) vaccination is? | |||
Yes | 89 (87.30) | 356 (99.70) | p = 8.74 × 10−10 |
No | 1 (1.00) | 0 (0.00) | |
I’m not sure | 12 11.80) | 1 (0.30) | |
Are you familiar with the schedule of mandatory vaccinations in Poland? | |||
Yes | 75 (73.50) | 262 (73.40) | p = 0.642 |
No | 5 (4.90) | 11 (3.10) | |
I am aware of it, but I am not familiar with the details | 22 (2.16) | 84 (23.50) | |
Have you heard of the MMR vaccine (measles, mumps, rubella)? | |||
Yes | 84 (82.40) | 319 (98.40) | p = 0.0567 |
No | 18 (17.60) | 39 (10.60) | |
Do you know why vaccination are important for public health? | |||
Yes | 87 (85.30) | 328 (91.9) | p = 0.0305 |
No | 5 (4.90) | 4 (1.10) | |
I’m not sure | 10 (9.80) | 25 (7.00) | |
Do you know what herd/community immunity is? | |||
Yes | 73 (71.60) | 325 (91.00) | p = 2.10 × 10−6 |
No | 4 (3.90) | 5 (1.40) | |
I am aware of it, but I am not familiar with the details. | 25 (24.50) | 27 (7.60) | |
Which disease has been eradicated worldwide thanks to vaccinations? | |||
Accurate response | 9 (8.80) | 60 (16.80) | p = 0.0466 |
Inaccurate response | 93 (91.20) | 297 (83.20) | |
Has your child received all mandatory vaccinations? | |||
Yes | 93 (91.20) | 343 (96.10) | p = 1.43 × 10−4 |
No | 4 (3.90) | 14 (3.90) | |
I’m not sure | 5 (4.90) | 0 (0.00) | |
If your child had adverse reactions after vaccination, were they reported to a doctor? | |||
Yes | 12 (63.20) | 35 (85.40) | p = 0.0521 |
No | 7 (36.80) | 6 (14.60) | |
Do you plan a vaccinate your child in the future according to the vaccination schedule? | |||
Yes | 87 (85.30) | 310 (86.80) | p = 0.774 |
No | 6 (5.90) | 15 (4.20) | |
I have not made a decision yet | 9 (8.80) | 32 (9.00) | |
Are you considering additional vaccinations for your child (e.g., against flu, HPV)? | |||
Yes | 31 (30.40) | 201 (56.30) | p = 2.92 × 10−7 |
No | 27 (26.50) | 89 (24.90) | |
I have not made a decision yet | 44 (43.10) | 67 (18.80) |
Answers to the Questionnaire Questions | Knowledge Level | Statistical Significance | ||
---|---|---|---|---|
Low Knowledge n = 48 N (%) | Moderate Knowledge n = 234 N (%) | High Knowledge n = 177 N (%) | p-Value | |
Has your child been vaccinated against measles? | ||||
Vaccinated | 21 (43.80) | 114 (48.70) | 143 (80.80) | p = 1.57 × 10−11 |
Not vaccinated | 27 (56.20) | 120 (51.30) | 34 (19.20) | |
Has your child been vaccinated against pertussis? | ||||
Vaccinated | 8 (16.70) | 101 (43.20) | 138 (78.00) | p = 7.47 × 10−18 |
Not vaccinated | 40 (83.30) | 133 (56.80) | 39 (22.00) | |
Has your child been vaccinated against both measles and pertussis? | ||||
Vaccinated against both | 7 (14.60) | 89 (38.00) | 128 (72.30) | p = 1.78 × 10−16 |
Other | 41 (85.40) | 145 (62.00) | 49 (27.70) | |
Has your child received all mandatory vaccinations? | ||||
Yes, received all mandatory vaccinations | 47 (97.90) | 213 (91.00) | 176 (99.40) | p = 3.46 × 10−4 |
No, did not receive all mandatory vaccinations | 1 (2.10) | 21 (9.00) | 1 (0.60) | |
Do you plan a vaccinate your child in the future according to the vaccination schedule? | ||||
Yes | 39 (81.20) | 183 (78.20) | 175 (98.80) | p = 5.34 × 10−9 |
No | 9 (18.80) | 51 (21.80) | 2 (1.10) | |
Are you considering additional vaccinations for your child (e.g., against flu, HPV)? | ||||
Yes | 10 (20.80) | 99 (42.30) | 123 (69.50) | p = 2.63 × 10−11 |
No | 38 (79.20) | 135 (57.70) | 54 (30.50) |
Variable VAX_1 | Low Mistrust n = 370 N (%) | High Mistrust n = 89 N (%) | OR | 95% CI | Statistical Significance |
Has your child received all mandatory vaccinations? | |||||
Yes | 369 (99.70) | 67 (75.30) | 0.0084 | 0.00021–0.05350 | 4.081131 × 10−16 |
No | 1 (0.30) | 22 (24.70) | |||
Has your child been vaccinated against measles? | |||||
Vaccinated | 243 (65.70) | 35 (39.30) | 0.5599 | 0.20387–0.5599 | 6.848 × 10−6 |
Not vaccinated | 127 (34.30) | 54 (60.70) | |||
Has your child been vaccinated against pertussis? | |||||
Vaccinated | 215 (58.10) | 32 (36.00) | 0.4055 | 0.24209–0.6709 | 0.0002186 |
Not vaccinated | 155 (41.90) | 57 (64.00) | |||
Has your child been vaccinated against measles and pertussis? | |||||
Vaccinated | 197 (53.20) | 27 (30.30) | 0.3832 | 0.22377–0.64266 | 0.0001382 |
Not vaccinated | 173 (46.80) | 62 (69.70) | |||
Education Level | |||||
Primary/Secondary | 84 (22.70) | 18 (20.20) | 1.1582 | 0.63951–2.18373 | 0.672 |
Higher education | 286 (77.30) | 71 (79.80) | |||
Are you considering additional vaccinations for your child (e.g., against flu, HPV)? | |||||
Yes | 227 (61.40) | 5 (5.60) | 0.03772 | 0.011652–0.09478 | <2.2 × 10−16 |
No | 143 (38.60) | 84 (94.40) | |||
Do you plan a vaccinate your child in the future according to the vaccination schedule? | |||||
Yes | 362 (97.80) | 35 (39.30) | 0.1459 | 0.00552–0.03397 | <2.2 × 10−16 |
No | 8 (2.20) | 54 (60.70) | |||
Variable VAX_2 | Minor Worry n = 170 N (%) | Severe Worry n = 289 N (%) | OR | 95% CI | Statistical significance |
Has your child received all mandatory vaccinations? | |||||
Yes | 170 (100.00) | 266 (92.00) | n.a. | n.a. | 0.000023 |
No | 0 (0.00) | 23 (8.00) | |||
Has your child been vaccinated against measles? | |||||
Vaccinated | 136 (80.00) | 142 (49.10) | 4.1277 | 2.61592–6.6392 | 3.988 × 10−11 |
Not vaccinated | 34 (20.00) | 147 (50.90) | |||
Has your child been vaccinated against pertussis? | |||||
Vaccinated | 117 (68.80) | 130 (45.00) | 2.6940 | 1.77982–4.11218 | 7.168 × 10−7 |
Not vaccinated | 53 (31.20) | 159 (55.00) | |||
Has your child been vaccinated against measles and pertussis? | |||||
Vaccinated | 114 (67.10) | 110 (38.10) | 3.3036 | 2.18362–5.03904 | 1.768 × 10−9 |
Not vaccinated | 56 (32.90) | 179 (61.90) | |||
Education Level | |||||
Primary/Secondary | 28 (16.50) | 74 (25.60) | 1.7435 | 1.05397–2.94501 | 0.02697 |
Higher education | 142 (83.50) | 215 (25.60) | |||
Are you considering additional vaccinations for your child (e.g., against flu, HPV)? | |||||
Yes | 125 (73.50) | 107 (37.00) | 4.7074 | 3.05792–7.3397 | 2.486 × 10−14 |
No | 45 (26.50) | 182 (63.00) | |||
Do you plan a vaccinate your child in the future according to the vaccination schedule? | |||||
Yes | 168 (98.80) | 229 (79.20) | 21.9237 | 5.6678–187.3108 | 4.978 × 10−11 |
No | 2 (1.20) | 60 (20.80) | |||
Variable VAX_3 | Mild Concerns n = 352 N (%) | Severe Concerns n = 108 N (%) | OR | 95% CI | Statistical significance |
Has your child received all mandatory vaccinations? | |||||
Yes | 349 (99.40) | 87 (80.60) | 0.024 | 0.002268–0.10109 | 2.1 × 10−12 |
No | 2 (0.60) | 21 (19.40) | |||
Has your child been vaccinated against measles? | |||||
Vaccinated | 229 (65.20) | 49 (45.40) | 0.4433 | 0.2787–0.70220 | 0.0002968 |
Not vaccinated | 122 (34.80) | 59 (54.60) | |||
Has your child been vaccinated against pertussis? | |||||
Vaccinated | 215 (61.30) | 32 (29.60) | 0.2671 | 0.1617–0.4336 | 1.093 × 10−8 |
Not vaccinated | 136 (38.70) | 76 (70.40) | |||
Has your child been vaccinated against measles and pertussis? | |||||
Vaccinated | 193 (55.00) | 31 (28.70) | 0.3304 | 0.1996–0.5369 | 1.794 × 10−6 |
Not vaccinated | 158 (45.00) | 77 (71.30) | |||
Education Level | |||||
Primary/Secondary | 72 (20.50) | 30 (27.80) | 0.6716 | 0.39998–1.14415 | 0.1144 |
Higher education | 279 (79.50) | 78 (72.20) | |||
Are you considering additional vaccinations for your child (e.g., against flu, HPV)? | |||||
Yes | 213 (60.70) | 19 (17.60) | 0.1389 | 0.07632–0.24217 | 1.005 × 10−15 |
No | 138 (39.30) | 89 (82.40) | |||
Do you plan a vaccinate your child in the future according to the vaccination schedule? | |||||
Yes | 337 (96.00) | 60 (55.60) | 0.0525 | 0.0251–0.1038 | <2.2 × 10−16 |
No | 14 (4.00) | 48 (44.40) | |||
Variable VAX_4 | Weak Preferences n = 358 N (%) | Strong Preferences n = 101 N (%) | OR | 95% CI | Statistical significance |
Has your child received all mandatory vaccinations? | |||||
Yes | 355 (99.20) | 81 (80.20) | 0.346 | 0.0064–0.1206 | 1.423 × 10−11 |
No | 3 (0.80) | 20 (19.80) | |||
Has your child been vaccinated against measles? | |||||
Vaccinated | 228 (63.70) | 50 (49.50) | 0.5597 | 0.34938–0.89563 | 0.0113 |
Not vaccinated | 130 (36.30) | 51 (50.50) | |||
Has your child been vaccinated against pertussis? | |||||
Vaccinated | 213 (59.50) | 34 (33.70) | 0.3463 | 0.2105–0.5617 | 5.147 × 10−6 |
Not vaccinated | 145 (40.5) | 67 (66.30) | |||
Has your child been vaccinated against measles and pertussis? | |||||
Vaccinated | 190 (53.10) | 34 (33.70) | 0.4495 | 0.2737–0.7280 | 0.0006825 |
Not vaccinated | 168 (46.90) | 67 (66.30) | |||
Vaccination Knowledge | |||||
Low vaccination knowledge | 32 (8.90) | 16 (15.80) | 0.5223 | 0.2637–1.0695 | 0.06366 |
Advanced vaccination knowledge | 326 (91.10) | 85 (84.20) | |||
Education Level | |||||
Primary/Secondary | 66 (18.40) | 36 (35.60) | 0.4090 | 0.2447–0.6880 | 0.0004033 |
Higher education | 292 (81.60) | 65 (64.40) | |||
Are you considering additional vaccinations for your child (e.g., against flu, HPV)? | |||||
Yes | 215 (60.10) | 17 (16.80) | 0.1352 | 0.07208–0.24113 | 5.657 × 10−15 |
No | 143 (39.90) | 84 (83.20) | |||
Do you plan a vaccinate your child in the future according to the vaccination schedule? | |||||
Yes | 3 (95.80) | 54 (53.50) | 0.0508 | 0.02456–0.09988 | <2.2 × 10−16 |
No | 15 (4.20) | 47 (46.50) |
Variable | Age (<39) n = 268 N (%) | Age (≥39) n = 191 N (%) | OR | 95% CI | Statistical Significance |
---|---|---|---|---|---|
Has your child received all mandatory vaccinations? | |||||
Yes | 250 (93.30) | 186 (97.40) | 2.67 | 0.934–9.383 | 0.04 |
No | 18 (6.70) | 5 (2.60) | |||
Has your child been vaccinated against measles? | |||||
Vaccinated | 163 (60.80) | 115 (60.20) | 0.97 | 0.655–1.452 | 0.59 |
Not vaccinated | 105 (39.20) | 76 (39.80) | |||
Has your child been vaccinated against pertussis? | |||||
Vaccinated | 148 (55.20) | 99 (51.80) | 0.87 | 0.591–1.288 | 0.79 |
Not vaccinated | 120 (44.80) | 92 (48.20) | |||
Has your child been vaccinated against measles and pertussis? | |||||
Vaccinated | 131 (48.90) | 93 (48.70) | 0.99 | 0.673–1.464 | 0.6 |
Not vaccinated | 137 (51.10) | 98 (51.30) | |||
Are you considering additional vaccinations for your child (e.g., against flu, HPV)? | |||||
Yes | 129 (48.10) | 103 (53.90) | 1.26 | 0.839–3.368 | 0.13 |
No | 139 (51.90) | 88 (46.10) | |||
Do you plan a vaccinate your child in the future according to the vaccination schedule? | |||||
Yes | 230 (85.80) | 167 (87.40) | 1.15 | 0.855–1.862 | 0.36 |
No | 38 (14.20) | 24 (12.60) | |||
Mistrust_VAX1 | |||||
Low Mistrust | 217 (81.00) | 153 (80.10) | 1.06 | 0.644–2.085 | 0.45 |
High Mistrust | 51 (19.00) | 38 (19.90) | |||
Worry_VAX2 | |||||
Minor Worry | 87 (32.50) | 83 (43.50) | 1.60 | 0.641–1.730 | 0.11 |
Severe Worry | 181 (67.50) | 108 (56.50) | |||
Concerns_VAX3 | |||||
Mild Concerns | 203 (75.70) | 148 (77.50) | 0.91 | 1.069–2.389 | 0.71 |
Severe Concerns | 65 (24.30) | 43 (22.50) | |||
Preferences | |||||
Weak Preferences | 211 (78.70) | 147 (77.00) | 1.11 | 0.569–1.439 | 0.37 |
Strong Preferences | 57 (21.30) | 44 (23.00) |
Answers to the Questionnaire Questions | N (%) N = 459 |
---|---|
Have there been any vaccination information campaigns organized at your child’s school? | |
Yes | 149 (32.46) |
No | 140 (30.50) |
Undecided | 170 (37.04) |
In your opinion, is vaccination-related information sufficiently accessible? | |
Yes | 206 (44.88) |
No | 156 (33.99) |
No opinion | 97 (21.13) |
Do you believe schools should be more involved in vaccination education? | |
Yes | 231 (50.33) |
No | 70 (15.25) |
Undecided | 158 (34.42) |
Are you aware of individuals in your social circle who choose not to vaccinate their children? | |
Yes | 281 (61.22) |
No | 139 (30.28) |
Unknow | 39 (8.50) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Nowicki, P.; Górajska, M.; Garus-Pakowska, A. Knowledge and Attitudes of Parents of School-Aged Children Regarding Vaccinations, and an Analysis of Measles and Pertussis Vaccination Coverage Using the Example of the City of Radomsko in Central Poland. Vaccines 2025, 13, 869. https://doi.org/10.3390/vaccines13080869
Nowicki P, Górajska M, Garus-Pakowska A. Knowledge and Attitudes of Parents of School-Aged Children Regarding Vaccinations, and an Analysis of Measles and Pertussis Vaccination Coverage Using the Example of the City of Radomsko in Central Poland. Vaccines. 2025; 13(8):869. https://doi.org/10.3390/vaccines13080869
Chicago/Turabian StyleNowicki, Paweł, Magdalena Górajska, and Anna Garus-Pakowska. 2025. "Knowledge and Attitudes of Parents of School-Aged Children Regarding Vaccinations, and an Analysis of Measles and Pertussis Vaccination Coverage Using the Example of the City of Radomsko in Central Poland" Vaccines 13, no. 8: 869. https://doi.org/10.3390/vaccines13080869
APA StyleNowicki, P., Górajska, M., & Garus-Pakowska, A. (2025). Knowledge and Attitudes of Parents of School-Aged Children Regarding Vaccinations, and an Analysis of Measles and Pertussis Vaccination Coverage Using the Example of the City of Radomsko in Central Poland. Vaccines, 13(8), 869. https://doi.org/10.3390/vaccines13080869